Monday December 10, 2018 07:36

Heathcare Press Release : 24 Dec 2014

EB Pharma Announces License Agreement for Investigational Drug, Tipifarnib from Janssen Heathcare—24 Dec 14

EB Pharma, LLC., a subsidiary of Eiger BioPharmaceuticals, Inc., today announced that it has executed an agreement with Janssen Pharmaceutica NV, ("Janssen"), for an exclusive license, to tipifarnib in the field of virology and a related, clinical stage